Eggerthella lenta: Difference between revisions
From IDWiki
Eggerthella lenta
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
* Most commonly associated with GI tract illness or with infected sacral ulcer |
* Most commonly associated with GI tract illness or with infected sacral ulcer |
||
* Can either be monomicrobial (including disseminated infection) or, more commonly, polymicrobial with an intraabominal infection |
* Can either be monomicrobial (including disseminated infection) or, more commonly, polymicrobial with an intraabominal infection |
||
== Management == |
|||
* When found in blood culture without focus, consider CT abdomen to rule out intraabdominal pathology |
|||
* Almost always susceptible to [[amoxicillin-clavulanate acid]], [[cefoxitin]], [[metronidazole]], [[piperacillin-tazobactam]], [[ertapenem]], and [[meropenem]] |
|||
* Generally susceptible to [[clindamycin]] |
|||
* Occasionally susceptible to [[fluoroquinolones]] |
|||
* Not reliably susceptible to [[penicillin]] |
|||
== Further Reading == |
== Further Reading == |
||
Latest revision as of 18:21, 23 May 2021
Background
- Anaerobic, non-sporulating, Gram-positive bacillus
Clinical Manifestations
- Most commonly associated with GI tract illness or with infected sacral ulcer
- Can either be monomicrobial (including disseminated infection) or, more commonly, polymicrobial with an intraabominal infection
Management
- When found in blood culture without focus, consider CT abdomen to rule out intraabdominal pathology
- Almost always susceptible to amoxicillin-clavulanate acid, cefoxitin, metronidazole, piperacillin-tazobactam, ertapenem, and meropenem
- Generally susceptible to clindamycin
- Occasionally susceptible to fluoroquinolones
- Not reliably susceptible to penicillin
Further Reading
- Clinical and Microbiological Characteristics of Eggerthella lenta Bacteremia. Clin Micro Rev. 2015;53(2):626-635. doi: 10.1128/JCM.02926-14
